Amoxicillin-Clavulanate Dosage for Pediatric Preseptal Cellulitis

First-Line Treatment

The American Academy of Pediatrics recommends high-dose amoxicillin-clavulanate at 80-90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate in 2 divided doses (maximum 2g per dose) as the treatment of choice for pediatric preseptal cellulitis, particularly for moderate to severe infections and for children who are younger than 2 years of age, attending childcare, or recently treated with antibiotics within the past 4-6 weeks 1, 2, 3
High-dose amoxicillin-clavulanate is recommended for children who are at high risk of treatment failure or disease progression, including those with recent antibiotic use 2, 3

The high-dose formulation provides adequate coverage against Moraxella catarrhalis, a common causative organism of preseptal cellulitis 2, 4

For children who cannot tolerate oral medication, a single 50 mg/kg dose of ceftriaxone given intravenously or intramuscularly can be used initially, followed by oral amoxicillin-clavulanate to complete the course 2
For patients with true penicillin allergy, Clindamycin (30-40 mg/kg/day in 3-4 doses) is recommended, with consideration of linezolid or consultation with infectious disease specialists for severe infections with MRSA concerns 1, 5

Treatment should continue for 10-14 days total, with assessment of response to therapy after 72 hours 2, 6
Some experts recommend continuing treatment until the patient has been symptom-free for 7 days 2

Evaluate for clinical improvement within 48-72 hours of starting therapy, and watch for signs of orbital involvement (proptosis, limited eye movement, vision changes) which would indicate progression to orbital cellulitis requiring hospitalization and IV antibiotics 1, 6
If symptoms worsen or fail to improve after 72 hours, consider imaging (CT scan) to rule out complications or orbital involvement 1

Underdosing amoxicillin component is a common mistake, and standard-dose amoxicillin alone should not be used for preseptal cellulitis as it may not provide adequate coverage against beta-lactamase producing organisms 2, 3, 4
In regions with high antibiotic resistance, be aware of local susceptibility patterns when selecting therapy 2, 3

The American Academy of Allergy, Asthma, and Immunology recommends continuing treatment for 10-14 days total, with some experts suggesting treatment until the patient has been symptom-free for 7 days, for children with preseptal cellulitis and concurrent purulent otitis media 7
For children <5 years who are inadequately vaccinated against Haemophilus influenzae type b, high-dose amoxicillin-clavulanate or second/third-generation cephalosporins are justified, according to the European Society of Clinical Microbiology and Infectious Diseases 8
In regions with high penicillin resistance in invasive pneumococcal strains, the Infectious Diseases Society of America recommends considering alternative agents, such as high-dose amoxicillin-clavulanate, for the treatment of preseptal cellulitis 9

Young children with preseptal cellulitis and concurrent purulent otitis media require high-dose therapy, as recommended by the American Academy of Pediatrics and the European Society of Clinical Microbiology and Infectious Diseases 7, 8